 
                            Pharma Giants Merck, Moderna Partner to Develop Cancer Vaccine Worth $100,000
Pharma giants Merck and Moderna have teamed up to develop a cancer vaccine which uses MRNA technology and specimens of genetic codes from patients’ tumors to stimulate the body to fight off cancer.
 
            
 
                             
                             
                             
                             
         
                             
                             
                             
                             
                            
Follow Us